Investors

    Investors

  • Overview
  • Company Presentations
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Financials and Filings
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • Financials and Filings

  • Balance Sheet
  • Income Statement
  • Cash Flow
  • Financial Results
  • All SEC Filings
  • Annual Reports
  • Quarterly Reports
  • Section 16 Filings

Section 16 Filings

Filter Filings:
Date Form Description View As Pages
03/20/18 3 Initial statement of beneficial ownership of securities 2
11/27/17 4 Statement of changes in beneficial ownership of securities 2
09/25/17 3 Initial statement of beneficial ownership of securities
Documents
EX-24
4
09/18/17 4 Statement of changes in beneficial ownership of securities 2
09/15/17 4 Statement of changes in beneficial ownership of securities 2
09/12/17 4 Statement of changes in beneficial ownership of securities 1
09/08/17 4 Statement of changes in beneficial ownership of securities 2
09/05/17 4 Statement of changes in beneficial ownership of securities 2
09/05/17 4 Statement of changes in beneficial ownership of securities 2
09/05/17 4 Statement of changes in beneficial ownership of securities 1
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • Investor

    ©2011-2019 Ekso Bionics Contact Us Privacy Policy

    *The Ekso™ (version 1.1) and Ekso GT™ (version 1.2) are intended to perform ambulatory functions in rehabilitation institutions under the supervision of a trained physical therapist for the following population with upper extremity motor function of at least 4/5 in both arms: Individuals with hemiplegia due to stroke; Individuals with spinal cord injuries at levels T4 to L5; Individuals with spinal cord injuries at levels of C7 to T3 (ASIA D).